Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Gains 5%; BSE HEALTHCARE Index Up 0.2%
Tue, 25 Jun 9:55

NEULAND LABS Gains 5%; BSE HEALTHCARE Index Up 0.2%Image source: Ivcandy/www.istockphoto.com

NEULAND LABS share price has zoomed 5% and is presently trading at Rs 7,022.7.

Meanwhile, the BSE HEALTHCARE index is at 36,799.8 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are KIMS (up 4.3%) and DR. LAL PATHLABS (up 2.3%).

ASTER DM HEALTHCARE (down 3.0%) and POLY MEDICURE (down 1.9%) are among the top losers today.

Over the last one year, NEULAND LABS has moved up from Rs 2,869.8 to Rs 7,022.7, registering a gain of Rs 4,152.9 (up 144.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,114.1 to 36,799.8, registering a gain of 46.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Natco Pharma (up 92.2%), Cadila Healthcare (up 91.9%) and Glenmark Pharma (up 90.1%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 77,598.0 (up 0.3%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 1.7%) and HDFC Bank (up 1.1%). The most traded stocks in the BSE Sensex are ICICI Bank and HDFC Bank.

In the meantime, NSE Nifty is at 23,615.7 (up 0.3%). Ultratech Cement and Hindalco are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,523.2 to 77,598.0, registering a gain of 14,074.8 points (up 22.2%).

NEULAND LABS Financial Update...

NEULAND LABS net profit fell 20.1% YoY to Rs 676 million for the quarter ended March 2024, compared to a profit of Rs 845 million a year ago. Net sales declined 5.4% to Rs 3,850 million during the period as against Rs 4,071 million in January-March 2023.

For the year ended March 2023, NEULAND LABS reported 156.2% increase in net profit to Rs 1,635 million compared to net profit of Rs 638 million during FY22. Revenue of the company grew 25.2% to Rs 11,912 million during FY23.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 30.0.


Equitymaster requests your view! Post a comment on "NEULAND LABS Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!